Spotlight Session - BRACE

(CSPOT25) Discrete Choice Experiment (DCE) as A Tool to Elicit Patient Preferences in A Complex Benefit-Risk Evaluation: A Rimonabant Case Study

(CSPOT27) A Comparative Analysis of Imposed Post-Authorization Measures for Advanced Therapy Medicinal Products Approved Between 2009-2013 in Europe and in United States of America

(CSPOT28) Limited impact of Direct Healthcare Professional Communications when using optimal outcomes and appropriate study populations: a systematic review.

(CSPOT29) Assessing use of the Reporting recommendation Intended for pharmaceutical Risk Minimization Evaluation Studies (RIMES) checklist in risk minimization evaluation studies in the EUPAS register

(CSPOT30) Identifying regulatory outcomes of Multi-Database and non- Multi-Database non-interventional Post Authorisation Safety Studies using publicly available information

(CSPOT31) Perspectives of People With Type 2 Diabetes Mellitus Towards a Decision Aid Assessing Preferences of Glucose-Lowering Drugs: The Dilemma of Choosing

(CSPOT32) Impact of risk communication on thrombosis with thrombocytopenia syndrome for COVID-19 adenovirus vector vaccines on European healthcare professionals